SGMO Shares Outstanding History



Below is a table of the SGMO shares outstanding history going back to 2/1/2010:

Date SGMO Shares Outstanding
2/1/201045.00M
4/30/201045.10M
7/30/201045.20M
10/29/201045.22M
2/1/201145.42M
4/29/201152.32M
7/29/201152.46M
10/31/201152.47M
2/1/201252.55M
4/30/201252.59M
7/31/201252.75M
10/31/201252.99M
2/1/201353.35M
4/30/201353.75M
7/31/201354.11M
10/31/201361.80M
2/1/201462.74M
4/24/201469.58M
4/30/201467.96M
7/23/201468.16M
10/22/201468.40M
2/1/201569.17M
4/24/201569.58M
8/4/201569.86M
10/26/201570.05M
2/1/201670.37M
5/2/201670.49M
8/1/201670.62M
10/24/201670.62M
2/24/201770.88M
5/5/201771.94M
7/31/201783.61M
11/3/201784.52M
2/15/201886.34M
5/1/2018101.49M
8/1/2018101.67M
11/1/2018102.09M
2/15/2019102.27M
5/3/2019115.36M
8/2/2019115.68M
11/1/2019115.94M
2/21/2020116.02M
5/5/2020140.88M
8/3/2020140.99M
10/30/2020141.44M
2/19/2021143.25M
4/30/2021143.88M
8/2/2021145.34M
11/1/2021145.67M
2/22/2022145.97M
5/2/2022146.69M
8/1/2022156.55M
10/31/2022163.88M
2/17/2023168.48M
5/4/2023171.83M
8/4/2023177.11M
10/30/2023177.35M
3/8/2024178.91M

Also see: SGMO Market Cap History
SGMO YTD Return
SGMO Historical Shares Outstanding:
+10.28% CAGR
SGMO Historical Shares Outstanding: +10.28% CAGR

Mouse over chart for data details
2/1/2010 ...3/8/2024
Sangamo BioSciences is a clinical-stage genomic medicine company focused on translating science into medicines. Co.'s clinical-stage product candidates are: Isaralgagene civaparvovec (ST-920), which is Co.'s wholly-owned gene therapy product candidate for the treatment of Fabry disease; SAR445136, which is Co.'s zinc finger nuclease gene-edited cell therapy product candidate for the treatment of sickle cell disease; TX200 for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and Giroctocogene fitelparvovec (SB-525), which is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A. We show 58 historical shares outstanding datapoints in our coverage of SGMO's shares outstanding history.

Understanding the changing numbers of SGMO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SGMO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SGMO by allowing them to research SGMO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree SGMO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Sangamo Therapeutics (SGMO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

SGMT Shares Outstanding History
SGRY Shares Outstanding History
SGTX Shares Outstanding History
SGYP Shares Outstanding History
SHC Shares Outstanding History
SHOT Shares Outstanding History
SHPH Shares Outstanding History
SIBN Shares Outstanding History
SIEN Shares Outstanding History
SIGA Shares Outstanding History
More Healthcare companies »

 

SGMO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.